The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry. Rationale, design and objectives
- 25 November 2020
- journal article
- research article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 35 (11) , 1029-1037
Abstract
Hypertension is a major risk factor for the development of heart failure with preserved ejection fraction (HFPEF) and blood pressure (BP) in itself is an important marker of prognosis. The association of BP levels, and hemodynamic parameters, measured by ambulatory blood pressure monitoring (ABPM), with outcomes, in patients with HFPEF is largely unknown. Patients with HFPEF have a substantial burden of co-morbidities and frailty. In addition there are marked geographic differences in HFPEF around the world. How these difference influence the association between BP and outcomes in HFPEF are unknown. The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry aims to assess the relevance of BP parameters, measured by ABPM, on the outcome of HFPEF patients worldwide. Additionally, the influence of other relevant factors such as frailty and co-morbidities will be assessed. Stable HFPEF patients with a previous hospitalization, will be included. Patients should be clinically and hemodynamically stable for at least 4 weeks before study inclusion. Specific data related to HF, biochemical markers, ECG and echocardiography will be collected. An ABPM and geriatric and frailty evaluation will be performed and the association with morbidity and mortality assessed. Follow up will be at least one year.Keywords
This publication has 53 references indexed in Scilit:
- Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trialAmerican Heart Journal, 2013
- The human sympathetic nervous system: its relevance in hypertension and heart failureEuropean Heart Journal, 2012
- Monitorización ambulatoria de la presión arterial e insuficiencia cardiacaHipertensión y Riesgo Vascular, 2011
- A Systematic Assessment of Causes of Death After Heart Failure Onset in the CommunityCirculation: Heart Failure, 2011
- Impact of Baseline Systolic Blood Pressure on Long-Term Outcomes in Patients With Advanced Chronic Systolic Heart Failure (Insights from the BEST Trial)The American Journal of Cardiology, 2010
- Relation of Systolic Blood Pressure to Survival in Both Ischemic and Nonischemic Systolic Heart FailureThe American Journal of Cardiology, 2008
- Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure TrialCirculation: Heart Failure, 2008
- Predictors of All-Cause Mortality in Clinical Ambulatory MonitoringHypertension, 2007
- Ambulatory blood pressure in heart failureEuropean Journal of Clinical Investigation, 2001
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990